Skip to main content

Postgraduate Course in Cardiometabolic Medicine 2026

-
City
London, UK
Type of event
on site

Invitation

Dear Colleagues

It is a pleasure to announce the 3rd Postgraduate Course in Cardiometabolic Medicine, a timely and highly acclaimed educational programme conceived by Zurich Heart House – London Heart House, King’s College, and Royal Brompton & Harefield Hospitals, which will address an unmet educational need.

Cardiometabolic disorders represent a cluster of interrelated risk factors, primarily dyslipidemia, hypertension, elevated fasting blood glucose, obesity and non-alcoholic steatohepatitis. A combination of several of these risk factors massively increases the incidence and mortality of coronary heart disease and stroke. The strong association between metabolic disorders and cardiovascular health delivers a compelling reason to improve awareness of this cluster by identifying the risk factors and inducing targeted interventions.

The Postgraduate Course in Cardiometabolic Medicine consists of a three-day programme. State of the art lectures alternate with a great variety of interactive sessions, including workshops, rapid fire sessions and hands-on imaging sessions.

The course offers a unique opportunity to become an expert in the seminal area of cardiometabolic medicine. We would be most happy to welcome you at the Royal Society of Medicine in central London to enjoy three days of interactive education for the benefit of your practice and your patients.
Sincerely,

Andrew Krentz
Thomas F. Lüscher
John E. Deanfield
Michael Papadakis
 


Programme

Day 1, Thursday, June 4th, 2026

Venue: Hallam Conference Centre, London

09:00 - 09:30 | REGISTRATION AND COFFEE
09:30 - 09:45 | Opening Session
09:30Welcome by the course directors & Course concept and structure 

 

09:45 - 11:30 | Session 1: Obesity I - Causes and mechanisms
Chairs: NN 
09:45Is obesity a disease? If so, how do we diagnose it? The ESC’s view 
10:05Obesity and inflammation 
10:25What links adiposity to CVD? 
10:45Obesity, comorbidities and CV prevention 
11:05Panel discussion 
11:30 - 12:00 | COFFEE 

 

12:00 - 12:30 | Keynote lecture
 How to address obesity globally? 
12:30 - 13:30 | Session 2: Lifestyle and cardiovascular prevention 
Chairs: NN 
12:30Nutrition: from diet to the microbiome 
12:45Exercise and sports for cardiovascular disease prevention 
13:00Is vaping the new smoking frontier? 
13:15Panel discussion 
13:30 – 14:15 | Industry Sponsored Symposium tbd
14:15 - 15:00 |  LUNCH BREAK

 

15:00 - 16:30 | Session 3: ASCVD Assessment I
Chairs: NN
15:002025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias  
15:20 LDL-C and cardiovascular disease: Why is lower better?     
15:40Hypertension: Lifestyle, medication or intervention? The 2024 ESC and ESH Guidelines on Hypertension 
16:00Panel discussion 
16:30 - 16:45 | COFFEE  
  
16:45 - 17:45 | Case-based interactive seminars I 
 Managing cardiovascular aspects in an athlete – case presentation     
 Cardiovascular Check-up in the general population – the EU strategy 

 

DAY 2, Friday, June 5th, 2026

09:00 - 10:45 | Session 4: ASCVD Assessment II & Management
Chairs: NN
09:00Multimodality imaging to assess ASCVD 
09:20Perivascular fat: Therapeutic target or surrogate of vascular disease? 
09:40Nucleic acids for LDL-C and Lipoprotein(a): anti-lipid effects and beyond 
10:00Remnant cholesterol and triglycerides: really a cardiovascular risk factor? 
10:20Panel discussion 
10:45 - 11:15 | COFFEE 

 

 
11:15 - 12:15 | Live demonstrations 
 Live in-a-box: Ergospirometry – how to do properly and interpret 
 Assessing vascular structure and function: a tool for primary prevention 
12:15 - 13:00 | Industry Sponsored Symposium
13:00 – 13:45 | LUNCH BREAK

 

13:45 - 15:10 | Session 5: Diabetes mellitus (DM) 
Chairs: NN
13:45Diabetes Type 2: Pathogenesis and management 
14:05Management of CVD risk in type 2 diabetes – the 2023 ESC Diabetes guidelines 
14:25GLP-1 and/or GIP and/or GLP-1 RAs for diabetes and beyond 
14:45Panel discussion 

 

15:10 - 16:10 | Session 6: Nephrology - Chronic Kidney Disease (CKD) – Causes & Mechanisms  
Chairs: NN
15:10CKD and cardiovascular risk     
15:30Albuminuria, eGFR slopes and outcomes: impact of pharmacotherapy 
15:50Panel discussion 
16:10 - 16:30 | COFFEE

 

16:30 - 17:10 | Session 7: Nephrology - Chronic kidney disease (CKD) - Management 
Chairs: NN
16:30SGLT2i and GLP1-RA in CKD and DKD – the 4 pillar approach 
16:50Aldosterone synthase inhibition vs. receptor antagonism: what is better?     
17:10Panel discussion 
17:30 – 18:30  |  Case-based interactive seminars II
 Managing type 2 diabetes and CVD risk – patient cases        
 Managing patients with CKD – patient cases     

DAY 3, Saturday, June 6th, 2026

09:00 - 10:00 | Session 8: Metabolic dysfunction-associated steatotic liver disease (MASLD) 
Chairs: NN
09:00Screening and diagnosis of MASLD     
09:20Management of MAFLD 
09:40Panel discussion 

 

10:00 - 11:00 | Session 9: Endocrinology and Cardiovascular disease 
Chairs: NN 
10:00Cardiovascular risk in classic endocrine disease 
10:20Sex hormones and CVD: in athletes and the population at large    
10:40Panel discussion 
11:00 - 11:30 | COFFEE 

 

11:30 - 12:30 | Session 10: Cardiovascular risk in myocardial disease 
Chairs: NN
11:30Managing amyloid heart disease: from stabilizers to siRNA and CRISPR-Cas9 
11:50Hypertrophic cardiomyopathy: diagnosis and management  
12:10Panel discussion 
12:30 - 13:30 | LUNCH 

 

13:30 - 15:00 | Session 11: Heart failure  
Chairs: NN
13:30Prevention and rehabilitation of heart failure 
13:50Management of heart failure: the 2021 and 2023 ESC guidelines 
14:10Prevention and rehabilitation in cancer patients 
14:30Panel discussion 
15:00 - 15:30 | COFFEE 
   
15:30 – 16:30  |  Case-based interactive seminars III 
 Diagnosing MASLD with Fibroscan – patient cases 
 Assessing HFpEF and HFrEF with echocardiography – patient cases 

The programme may be subject to change.


 

Information

Registration

Category 
Registration fees 
Early registration fee (until May 3rd, 2026)GBP 400
Regular course feeGBP 450
Early registration fee (until May 3rd, 2026): Trainees/Residents, Research fellows, Nurses, Students <40 years (ID proof required)*GBP 200
Trainees/Residents, Research fellows, Nurses, Students <40 years (ID proof required)*GPB 250
Day TicketsGPB 150

*For the reduced registration (Trainees/Residents, Research fellows, Nurses, Students <40 years) please send a copy of your ID to Ms. Christine Lohmann at christine.lohmann@zhh.ch

Registration will be confirmed upon receipt of payment.
Please note that UK banks may charge high fees for international bank transfers. We therefore recommend payment by credit card.

Travel Information

Travel to London

You must have a valid passport to enter the UK. It should be valid for the whole of your stay. You may also need a visa, depending on which country you’re from and the reason for your stay. Check if you need a visa to come to the UK. You must have your visa before you travel to the UK.

Electronic travel authorisation (ETA) 

From 2 April 2025, EU citizens will require an Electronic Travel Authorisation (ETA) to enter the UK. For non-EU citizens, the regulation will come into force on 8 January 2025. More information can be found on https://www.gov.uk/guidance/apply-for-an-electronic-travel-authorisation-eta. It will be possible to apply for the ETA, which will be required from April, from 5 March 2025 onwards. For nationals of certain countries outside Europe, the ETA will be required from 8 January 2025. The application is again possible from 27 November 2024: https://www.gov.uk/guidance/check-when-you-can-get-an-electronic-travel-authorisation-eta. You won’t have to apply in case you have a VISA.

Modification & Cancellation

All modifications or cancellations must be notified in writing (by mail, fax or e-mail) to Zurich Heart House. For each modification requested by the participant, GBP 15 will be charged for administrative costs. In case of cancellation up to May 8th, 2026, deposits will be refunded less 35% for administrative costs. After this date, no refund will be possible.

Venue

Hallam Conference Centre, London,
Cavendish Venues - 44 Hallam Street, W1, United Kingdom

 

Organisation

Zurich Heart House, / London Heart House, Foundation for Cardiovascular Research
Eleanor Wicks
Christine Lohmann
Hottingerstrasse 14, CH-8032 Zurich, Switzerland
Phone +41 (0) 44 250 40 95 
www.zhh.ch / www.londonhearthouse.uk 


Organized by

Anmeldeschluss